http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#head http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#assertion http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#provenance http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#publicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#assertion http://bio2rdf.org/drugbank:DB00176 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00176_DB00726 http://bio2rdf.org/drugbank:DB00726 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00176_DB00726 http://bio2rdf.org/drugbank_resource:DB00176_DB00726 http://purl.org/dc/terms/identifier drugbank_resource:DB00176_DB00726 http://bio2rdf.org/drugbank_resource:DB00176_DB00726 http://purl.org/dc/terms/title DDI between Fluvoxamine and Trimipramine - The strong CYP2C19 inhibitor, fluvoxamine, may decrease the metabolism and clearance of trimipramine, a CYP2C19 substrate. Additive modulation of serotonin activity may also increase the risk of serotonin syndrome. Consider alternate therapy or monitor for serotonin syndrome and changes in therapeutic and adverse effects of trimipramine if fluvoxamine is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00176_DB00726 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00176_DB00726 http://www.w3.org/2000/01/rdf-schema#label DDI between Fluvoxamine and Trimipramine - The strong CYP2C19 inhibitor, fluvoxamine, may decrease the metabolism and clearance of trimipramine, a CYP2C19 substrate. Additive modulation of serotonin activity may also increase the risk of serotonin syndrome. Consider alternate therapy or monitor for serotonin syndrome and changes in therapeutic and adverse effects of trimipramine if fluvoxamine is initiated, discontinued or dose changed. [drugbank_resource:DB00176_DB00726] http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#provenance http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#publicationInfo http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#signature.MCwCFG9m-ctyPIh5 http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#signature.MCwCFG9m-ctyPIh5 http://purl.org/nanopub/x/hasSignature MCwCFG9m+ctyPIh56scwOOc4BVIlaA2qAhRGu7b5iPyRIu+x3eBVZM7521PHxQ== http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#signature.MCwCFG9m-ctyPIh5 http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0 http://purl.org/dc/terms/created 2018-03-30T11:12:28.902+02:00 http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0#signature.MCwCFG9m-ctyPIh5 http://bio2rdf.org/drugbank_resource:DB00176_DB00726_nanopub.RA2-G4kcXWTSPt64ZXrhFrFm62Gc8GvTKOizE78_SvPZ0 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234